MiCAN Technologies Co., Ltd. (Headquarters: Kyoto City, Representative Director: Kazuo Miyazaki) has obtained certification for the international standard for quality management systems (Quality Management System), ISO 9001, on December 20, 2024.
ISO 9001 is an international standard established to achieve customer satisfaction and continuous improvement of quality management systems.
Our company is committed to contributing to the health of people around the world through the use of specialized blood cells derived from regenerative medicine technology. The Monocyte Activation Test (MAT) using aMylc cells produced with our proprietary technology is an alternative to animal testing methods and can detect both endotoxin and non-endotoxin pyrogenic substances with high sensitivity and stability.
Under the quality management system based on the international standards for which we have recently obtained certification, we will strive to provide products that earn the trust and satisfaction of our customers.
